Risk factors for acute graft-versus-host disease in allogeneic blood stem cell transplant recipients.

被引：0
|
作者：
Przepiorka, D [1 ]
Anderlini, P [1 ]
Ippoliti, C [1 ]
Khouri, I [1 ]
Folloder, J [1 ]
Ueno, N [1 ]
Mehra, R [1 ]
Giralt, S [1 ]
Gajewski, J [1 ]
Cleary, K [1 ]
Claxton, D [1 ]
Andersson, B [1 ]
Korbling, M [1 ]
Champlin, R [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON CANC CTR,HOUSTON,TX
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：441 / 441
页数：1
相关论文
共 50 条
  • [1] Acute Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Risk Factors and Spectrum of Infectious Complications
    Stoma, Igor
    Karpov, Igor
    Milanovich, Natalia
    Krivenko, Svetlana
    Iskrov, Igor
    Uss, Anatoly
    TRANSPLANTATION, 2018, 102 : S674 - S674
  • [2] Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation
    Przepiorka, D
    Smith, TL
    Folloder, J
    Khouri, I
    Ueno, NT
    Mehra, R
    Körbling, M
    Huh, YO
    Giralt, S
    Gajewski, J
    Donato, M
    Cleary, K
    Claxton, D
    Braunschweig, I
    van Besien, K
    Andersson, BS
    Anderlini, P
    Champlin, R
    BLOOD, 1999, 94 (04) : 1465 - 1470
  • [3] Association of whole blood tacrolimus (TCL) levels with acute graft-versus-host disease (AGVHD) and nephrotoxicity in allogeneic marrow or blood stem cell transplant recipients.
    Jacobson, PA
    Ratanatharathorn, V
    Ma, M
    Scalzo, A
    Wagner, L
    Schork, MA
    Silver, SM
    Adams, PT
    Uberti, JP
    BLOOD, 1997, 90 (10) : 4410 - 4410
  • [4] Infliximab for the treatment of steroid refractory graft-versus-host disease in allogeneic transplant recipients.
    Hicks, K
    Ippoliti, C
    Donato, M
    Champlin, R
    Khouri, I
    Andersson, B
    Anderlini, P
    Gajewski, J
    Giralt, S
    BLOOD, 1999, 94 (10) : 155A - 155A
  • [5] Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients
    Chen, Chien-Ting
    Liu, Chun-Yu
    Yu, Yuan-Bin
    Liu, Chia-Jen
    Hsiao, Liang-Tsai
    Gau, Jyh-Pyng
    Chiou, Tzeon-Jye
    Liu, Jing-Hwang
    Liu, Yao-Chung
    PLOS ONE, 2017, 12 (09):
  • [6] Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients Is an Important Risk Factor Not Only for Acute Graft-Versus-Host Disease but Also for Chronic Graft-Versus-Host Disease
    Jin, Hua
    Liu, Qifa
    BLOOD, 2017, 130
  • [7] RISK FACTORS FOR GRAFT-VERSUS-HOST DISEASE IN LIVER TRANSPLANT RECIPIENTS
    Lee, Frank
    Watt, Kymberly
    Chesdachai, Supavit
    Diwan, Tayyab
    Taner, Timucin
    Rosen, Charles B.
    Leise, Michael D.
    Heimbach, Julie
    HEPATOLOGY, 2023, 78 : S342 - S342
  • [8] Evaluation of Tacrolimus Levels and Risk of Acute Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant
    Huynh, David Anh Huy
    Freeman, Tracelyn
    Marshall, Vincent
    Markstrom, Denise
    Frame, David
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [9] Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease
    Krishna, Gopal
    Martinho, Monika
    Chandrasekar, Pranatharthi
    Ullmann, Andrew J.
    Patino, Hernando
    PHARMACOTHERAPY, 2007, 27 (12): : 1627 - 1636
  • [10] IS LIVER BIOPSY NECESSARY IN THE MANAGEMENT OF ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS WITH GRAFT-VERSUS-HOST DISEASE?
    Ye, J. C.
    Hukku, S.
    Bentley, G.
    Lebeis, T.
    Ratanatharathorn, V
    Ayash, L.
    Abidi, M. H.
    Al-Kadhimi, Z.
    Deol, A.
    Mellert, K.
    Uberti, J. P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S364 - S364
12345